N Ishida, N Odani-Kawabata, A Shimazaki, H … - Cardiovascular drug reviews, 2006 - interscience.wiley.com Elevated intraocular pressure (IOP) is one of the most important risk factors
for the development of glaucoma, which is a progressive optic neuropathy.
Lowering IOP is currently the only therapeutic approach to the therapy of ... Cited by 11 - Related articles - BL Direct - All 4 versions
- ►oculist.net [PDF] TW HEJKAL, CB CAMRAS - Glaucoma Medical Therapy: Principles and …, 2007 - books.google.com Prostaglandin Analogs THOMAS W. HEJKAL AND CARL B. CAMRAS Prostaglandin (PG)
analogs, originally introduced for glaucoma therapy in the United States with
latanoprost in 1996, have rapidly become the most commonly used ocular ... Cited by 5 - Related articles - BL Direct - All 3 versions
KY Wu, HZ Wang, SJ Hong - Current Eye Research, 2005 - informahealthcare.com Purpose: Latanoprost reduces intraocular pressure mainly by enhancing
uveoscleral outflow that may be involved in the decreased of extracellular
matrixes such as collagens. However, the effect of latanoprost on corneal ... Cited by 4 - Related articles - BL Direct - All 8 versions
S Ishibashi, N Hirose, A Tawara, T Kubota - Journal of Glaucoma, 2006 - journals.lww.com Cited Here...: Twenty-two eyes from 22 patients with NTG were used for the
study. The diurnal variations in the IOP and blood pressure (BP) were measured
every 3 hours without therapy, and then the patients were treated with ... Cited by 3 - Related articles - BL Direct - All 3 versions
CW Lee, F Buckley, S Costello, S Kelly - Current Medical Research and Opinion®, 2008 - informahealthcare.com Results: A total of 510 publications were identified. Of these, 181 studies had
a prostaglandin treatment arm. The median study duration was 12 weeks (IQR
4–13) and 78% of included trials had a duration of 3 months or less. The ... Cited by 1 - Related articles - All 7 versions
GS Ang, JP Kersey, L Shepstone, DC … - British Medical Journal, 2008 - bjo.bmj.com Results: Data from 88 participants were analysed—54 were randomised to
treatment and 34 to the control group. The mean duration of treatment was 6
months. The average, maximum and minimum diurnal IOPs for treated patients ... Cited by 1 - Related articles - All 4 versions
M Tsuda, A Ando, K Matsuyama, T Otsuji, C … - Journal of Ocular Pharmacology and Therapeutics, 2009 - liebertonline.com It has been reported that approximately 30% of Caucasian patients with glaucoma
have intraocular pressure (IOP) within a statistically normal range,1 while the
Tajimi study revealed that the ratio of patients with normal tension glau- ... Related articles - All 2 versions
MH Suh, KH Park, DM Kim - Japanese Journal of Ophthalmology, 2009 - Springer Netland et al. 7 suggested that the response to travoprost is better than that
to latanoprost or timolol in patients with IOP < 16 mmHg. As a result, it is
generally believed to be effective in lowering IOP in eyes with ... Related articles - All 2 versions
